Page 122 - IJB-10-1
P. 122

International Journal of Bioprinting                              Droplet-based bioprinting of tumor spheroids




            Table 2. Representative tumor spheroids fabricated by droplet-based bioprinting
             Tumor     Fabrication   Printing ma-  Cell types,   Viability   Culture   Spheroid   Morphology and   Ref.
                       method       trixes (% w/v)  (concentration   (%)  time (days)  diameter   physiological
                                                [× 10 cells/ml])               (μm)      responses
                                                   7
             Neuroblastic   Microvalve-based   Alginate  SK-N-BE(2) (25)  >95  3  ~200   Expression of   74
             tumor     bioprinting                                                       Ki67 protein,
                                                                                         HIF1α-positive
                                                                                         cells, cell ratio,
                                                                                         and distribution
             REC       Piezoelectric ink-  Matrigel-colla-  iREC (0.5–2.5)  ~92  7  ~50  Spheroid      76
             spheroid  jet bioprinting  gen I, Fibrin-                                   diameter, inner
                                    ogen                                                 structure, kid-
                                                                                         ney-specific gene
                                                                                         signatures
             Liver tumor  Microfluidic   Neural collagen  HepG2 (5) +   >90  7  ~250     Expression of   80
                       bioprinting  solution (4%)  EA.hy926 (5)                          MRP2, albumin,
                                                                                         and CD31, blood
                                                                                         vessels
                                    DMEM (90%)  HepG2 + HSC   ~98    6         100       Type I collagen,   81
                                                (a total number                          spheroid size, and
                                                of 100, the ratio                        morphology
                                                of HSCs ranges
                                                from 0% to
                                                100%)
             hESC      Microvalve-based   hESC SFM  hESCs (0.3)  >89  3        250–600   Spheroid mor-  42
             spheroid  bioprinting                                                       phology, Oct-4
                                                                                         pluripotency
                                                                                         marker
             Breast tumor  Microvalve-based   Gelatin (3%)  MCF-7 (0.1)  >95  7  200     Spheroid mor-  86
                       bioprinting                                                       phology, size, and
                                                                                         compactness
             Colorectal   Microvalve-based   Gelatin (1%)–   SW620 (0.015)  ~80  7  ~200  Spheroid     87
             tumor     bioprinting  alginate (10%)                                       morphology,
                                                                                         compactness, and
                                                                                         inner structure
             Oral tumor  Acoustic bioprint-  Gelatin (5%)  CAL27 (10) +   >94  5  ~100   Cell distribution   46
                       ing                      CAFs (10)                                in microenviron-
                                                                                         ment
            Abbreviations: DMEM, Dulbecco’s Modified Eagle Medium; hESC, human embryonic stem cell; HIF1α, hypoxia-inducible factor 1-alpha; MRP2, multi-
            drug resistance-associated protein 2; Oct-4, octamer-binding transcription factor 4; SFM, serum- and feeder-free medium.

            manner. Compared to non-structured renal spheroid,   at over 98%. By measuring the size and secretion of type
            the EA.hy 926 cells covered the surface of the structured   I collagen of finally formed multicellular spheroids, they
            spheroid and maintained the stability of morphology of   demonstrated that the initial ratio of HSCs and HepG2
            the liver spheroid for 10 days. They also found that the   cells affected the morphology and function of these
            gene expression of multidrug resistance-associated protein   spheroids. Compared with common random loading
            2 (MRP2), albumin, and CD31 was upregulated in the co-  process, single-cell printing produced liver spheroids that
            cultures. To match the complexity of liver tumors in vivo,   were more uniform.
            Zhang et al. utilized microfluidic flow cytometric printing
            technology to print HepG2 and HSC cells into microwells   3.4. Human embryonic stem cell spheroids
            for multicellular liver spheroid fabrication (Figure 3D).    Human embryonic stem  cells  (hESCs) can  proliferate
                                                         81
            As a cell-by-cell fabrication method, microfluidic flow   infinitely  and  differentiate  into  any  functional  cells  in
            cytometric printing technology allows for the control   vitro.  hESC spheroids can be utilized to study the
                                                                   82
            of cell numbers and types for each spheroid. Using this   formation  of  tumors.  However,  hESCs  are  very  fragile
            method, they found that cell viability could be maintained   and  can  spontaneously  differentiate  when  stimulated

            Volume 10 Issue 1 (2024)                       114                          https://doi.org/10.36922/ijb.1214
   117   118   119   120   121   122   123   124   125   126   127